Gene Therapy and Cancer Treatment
Insights Care Magazine (the best global online healthcare magazine) spoke recently with Dr. Óscar Juan, Senior Medical Manager at Pivotal, about Gene Therapy and Cancer Treatment.
“Gene therapy represents a...
News
Pivotal among the 10 Most Innovative CROs to Watch
Insights Care Magazine (the best global online healthcare magazine) spoke recently with Dr. Ibrahim Farr, Chairman & CEO at Pivotal, about the profound overview of Pivotal’ s...
Race against Cancer
Pivotal employees have shown to be very motivated and active again to participate in the race against Cancer held recently in Madrid. The main goal was to run...
Merry Christmas & Happy New Year
We would like to wish you a Merry Christmas and a Happy New Year as well as to thank you for your confidence and support throughout the years.
...
Pivotal among the 10 Most Reliable CRO´s to Watch
The Insights Care Magazine recently interviewed Dr. Ibrahim Farr, Chairman & CEO at Pivotal, about the company’s journey and how it has developed into...
Pivotal among the 10 Top Pharma Outsourcing Companies in Europe
The Pharma Tech Outlook magazine spoke recently with Dr. Ibrahim Farr, Chairman & CEO at Pivotal, about the company’s overview as already an established European-focused CRO.
“We have...
Pivotal among the 10 Best Healthcare Companies to Watch
The Silicon Review magazine spoke recently with Dr. Ibrahim Farr, Chairman & CEO at Pivotal, about the company’s main services, the new challenges ahead and what will...
Highlight Therapeutics and Pivotal work together on Melanoma therapy and launch a Phase IIa trial to examine BO-112 efficacy and safety
- Trial will examine administration of Highlight’s BO-112 in combination with an anti-PD1 in unresectable or metastatic melanoma patients
- Recruitment has already begun across 19 top-level centers in Spain and...
New Website
We are very excited to announce the launch of our newly designed website. Our goal with this new website is to provide our visitors with a more comprehensive grasp...